Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Inventory Average (2016 - 2026)

Cytosorbents filings provide 14 years of Inventory Average readings, the most recent being $4.6 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 55.21% to $4.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.6 million, a 55.21% increase, with the full-year FY2025 number at $4.0 million, up 31.19% from a year prior.
  • Inventory Average hit $4.6 million in Q4 2025 for Cytosorbents, up from $3.9 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $5.2 million in Q2 2022 to a low of $1.9 million in Q2 2023.
  • Median Inventory Average over the past 5 years was $3.5 million (2022), compared with a mean of $3.6 million.
  • Biggest five-year swings in Inventory Average: crashed 63.82% in 2023 and later skyrocketed 113.58% in 2024.
  • Cytosorbents' Inventory Average stood at $4.6 million in 2021, then fell by 24.65% to $3.5 million in 2022, then dropped by 9.28% to $3.2 million in 2023, then dropped by 5.86% to $3.0 million in 2024, then soared by 55.21% to $4.6 million in 2025.
  • The last three reported values for Inventory Average were $4.6 million (Q4 2025), $3.9 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.